I. Related cell sub types
ID | Name | Number of studies  | |
|---|---|---|---|
| CL_0001061 | abnormal cell | 13 | |
| CL_0000000 | cell | 0 |
ID | Name | Number of studies | |
|---|---|---|---|
| CL_0001061 | abnormal cell | 13 | |
| CL_0000000 | cell | 0 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
|---|---|---|---|---|---|
| POMZP3 | 3 | 17% ± 0% | 0 | 0 | |
| LYPD1 | 4 | 23% ± 5% | 1 | 1 | |
| ENPP3 | 3 | 20% ± 2% | 1 | 1 | |
| NBPF9 | 3 | 19% ± 4% | 1 | 1 | |
| DEDD | 3 | 18% ± 2% | 1 | 1 | |
| POLR2J2 | 3 | 25% ± 2% | 1 | 1 | |
| ZNF3 | 3 | 17% ± 2% | 1 | 2 | |
| NMB | 3 | 27% ± 4% | 1 | 3 | |
| PRLR | 3 | 26% ± 11% | 1 | 4 | |
| CRYZ | 4 | 24% ± 2% | 2 | 5 | |
| DYNC2I2 | 4 | 19% ± 3% | 2 | 7 | |
| RCC1L | 3 | 19% ± 2% | 2 | 2 | |
| TNNT1 | 3 | 27% ± 15% | 2 | 2 | |
| TBC1D17 | 3 | 16% ± 1% | 2 | 2 | |
| SPATA20 | 3 | 17% ± 1% | 2 | 2 | |
| NBPF15 | 3 | 21% ± 0% | 2 | 2 | |
| RNF40 | 3 | 18% ± 4% | 2 | 2 | |
| ABHD11 | 3 | 18% ± 2% | 2 | 5 | |
| CDKN2A | 3 | 49% ± 7% | 2 | 7 | |
| S100A1 | 4 | 35% ± 10% | 3 | 6 | |
| PDZK1IP1 | 5 | 35% ± 17% | 3 | 17 | |
| MAL2 | 5 | 28% ± 15% | 3 | 18 | |
| PPP1R16A | 4 | 22% ± 4% | 3 | 8 | |
| CDK16 | 3 | 26% ± 7% | 3 | 3 | |
| EHMT2 | 3 | 17% ± 1% | 3 | 3 | |
| PLOD3 | 4 | 27% ± 8% | 4 | 5 | |
| NOL3 | 4 | 30% ± 14% | 4 | 6 | |
| NDUFA4L2 | 4 | 61% ± 25% | 4 | 7 | |
| LSR | 5 | 21% ± 3% | 4 | 18 | |
| PLOD1 | 4 | 20% ± 2% | 4 | 8 |
| GO_0046500 | Biological process | S-adenosylmethionine metabolic process |
| GO_0034333 | Biological process | adherens junction assembly |
| GO_0043278 | Biological process | response to morphine |
| GO_0035989 | Biological process | tendon development |
| GO_0044387 | Biological process | negative regulation of protein kinase activity by regulation of protein phosphorylation |
| GO_0015757 | Biological process | galactose transmembrane transport |
| GO_0003179 | Biological process | heart valve morphogenesis |
| GO_0030262 | Biological process | apoptotic nuclear changes |
| GO_0031116 | Biological process | positive regulation of microtubule polymerization |
| GO_0070837 | Biological process | dehydroascorbic acid transport |
| GO_0007413 | Biological process | axonal fasciculation |
| GO_0060008 | Biological process | Sertoli cell differentiation |
| GO_0031345 | Biological process | negative regulation of cell projection organization |
| GO_0035332 | Biological process | positive regulation of hippo signaling |
| GO_0046903 | Biological process | secretion |
| GO_0051220 | Biological process | cytoplasmic sequestering of protein |
| GO_0021952 | Biological process | central nervous system projection neuron axonogenesis |
| GO_0006620 | Biological process | post-translational protein targeting to endoplasmic reticulum membrane |
| GO_0060996 | Biological process | dendritic spine development |
| GO_0035993 | Biological process | deltoid tuberosity development |
| GO_2000278 | Biological process | regulation of DNA biosynthetic process |
| GO_0034122 | Biological process | negative regulation of toll-like receptor signaling pathway |
| GO_0061035 | Biological process | regulation of cartilage development |
| GO_0048713 | Biological process | regulation of oligodendrocyte differentiation |
| GO_1902109 | Biological process | negative regulation of mitochondrial membrane permeability involved in apoptotic process |
| GO_0045048 | Biological process | protein insertion into ER membrane |
| GO_0014808 | Biological process | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
| GO_0006995 | Biological process | cellular response to nitrogen starvation |
| GO_0051387 | Biological process | negative regulation of neurotrophin TRK receptor signaling pathway |
| GO_0036506 | Biological process | maintenance of unfolded protein |
| Cell type name | abnormal cell |
| Synonyms | |
| Description | A cell found in an organism or derived from an organism exhibiting a phenotype that deviates from the expected phenotype of any native cell type of that organism. Abnormal cells are typically found in disease states or disease models. |
| Parent |
